These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18633104)

  • 21. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased central adiposity and decreased subcutaneous adipose tissue 11β-hydroxysteroid dehydrogenase type 1 are associated with deterioration in glucose tolerance-A longitudinal cohort study.
    Crowley RK; Woods CP; Hughes BA; Gray J; McCarthy T; Taylor AE; Gathercole LL; Shackleton CHL; Crabtree N; Arlt W; Stewart PM; Tomlinson JW
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):72-81. PubMed ID: 30667079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
    Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
    Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender-Specific Differences in Skeletal Muscle 11β-HSD1 Expression Across Healthy Aging.
    Hassan-Smith ZK; Morgan SA; Sherlock M; Hughes B; Taylor AE; Lavery GG; Tomlinson JW; Stewart PM
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2673-81. PubMed ID: 25989394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
    Tomlinson JW; Sherlock M; Hughes B; Hughes SV; Kilvington F; Bartlett W; Courtney R; Rejto P; Carley W; Stewart PM
    J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Obesity and Insulin on Tissue-Specific Recycling Between Cortisol and Cortisone in Men.
    Anderson AJ; Andrew R; Homer NZM; Hughes KA; Boyle LD; Nixon M; Karpe F; Stimson RH; Walker BR
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1206-e1220. PubMed ID: 33270115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
    Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
    Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
    Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.
    Li G; Hernandez-Ono A; Crooke RM; Graham MJ; Ginsberg HN
    Metabolism; 2012 Jun; 61(6):823-35. PubMed ID: 22209663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans.
    Stimson RH; Andersson J; Andrew R; Redhead DN; Karpe F; Hayes PC; Olsson T; Walker BR
    Diabetes; 2009 Jan; 58(1):46-53. PubMed ID: 18852329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X; Chen F; Zhu C; Lu Y
    J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
    Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats.
    Drake AJ; Livingstone DE; Andrew R; Seckl JR; Morton NM; Walker BR
    Endocrinology; 2005 Feb; 146(2):913-9. PubMed ID: 15550507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
    Morgan SA; Sherlock M; Gathercole LL; Lavery GG; Lenaghan C; Bujalska IJ; Laber D; Yu A; Convey G; Mayers R; Hegyi K; Sethi JK; Stewart PM; Smith DM; Tomlinson JW
    Diabetes; 2009 Nov; 58(11):2506-15. PubMed ID: 19675138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
    Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
    J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men.
    Stimson RH; Johnstone AM; Homer NZ; Wake DJ; Morton NM; Andrew R; Lobley GE; Walker BR
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4480-4. PubMed ID: 17785367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance.
    Andrews RC; Herlihy O; Livingstone DE; Andrew R; Walker BR
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5587-93. PubMed ID: 12466357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta-hydroxysteroid dehydrogenase 1 and autocrinal regulation.
    Park SY; Bae JH; Cho YS
    Cell Biochem Funct; 2014 Apr; 32(3):249-57. PubMed ID: 24122936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.